v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Class A Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Retained (loss) Earnings
Beginning balance (in shares) at Feb. 03, 2024   305.7      
Beginning balance at Feb. 03, 2024 $ 1,338.6 $ 0.1 $ 1,634.9 $ (83.6) $ (212.8)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (32.3)       (32.3)
Foreign currency translation adjustment 0.3     0.3  
Stock-based compensation expense, net 0.6   0.6    
Unrealized gain on Marketable Securities and gain on available-for-sale securities 0.2     0.2  
Settlement of stock-based awards (in shares)   0.5      
Settlement of stock-based awards 0.0        
Ending balance (in shares) at May. 04, 2024   306.2      
Ending balance at May. 04, 2024 1,307.4 $ 0.1 1,635.5 (83.1) (245.1)
Beginning balance (in shares) at Feb. 03, 2024   305.7      
Beginning balance at Feb. 03, 2024 1,338.6 $ 0.1 1,634.9 (83.6) (212.8)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 0.0        
Foreign currency translation adjustment $ 1.1        
Ending balance (in shares) at Nov. 02, 2024 446.8 446.8      
Ending balance at Nov. 02, 2024 $ 4,804.5 $ 0.2 5,099.7 (82.3) (213.1)
Beginning balance (in shares) at May. 04, 2024   306.2      
Beginning balance at May. 04, 2024 1,307.4 $ 0.1 1,635.5 (83.1) (245.1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 14.8       14.8
Foreign currency translation adjustment 0.1     0.1  
Stock-based compensation expense, net 5.4   5.4    
Issuance of common stock, net of cost (in shares)   120.3      
Issuance of common stock, net of cost 3,055.7 $ 0.1 3,055.6    
Ending balance (in shares) at Aug. 03, 2024   426.5      
Ending balance at Aug. 03, 2024 4,383.4 $ 0.2 4,696.5 (83.0) (230.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 17.4       17.4
Foreign currency translation adjustment 0.7     0.7  
Stock-based compensation expense, net 4.9   4.9    
Unrealized gain on Marketable Securities and gain on available-for-sale securities (0.2)       (0.2)
Settlement of stock-based awards (in shares)   0.3      
Issuance of common stock, net of cost (in shares)   20.3      
Issuance of common stock, net of cost $ 398.3   398.3    
Ending balance (in shares) at Nov. 02, 2024 446.8 446.8      
Ending balance at Nov. 02, 2024 $ 4,804.5 $ 0.2 5,099.7 (82.3) (213.1)
Beginning balance (in shares) at Feb. 01, 2025 447.0 447.0      
Beginning balance at Feb. 01, 2025 $ 4,929.8 $ 0.2 5,105.1 (94.0) (81.5)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 44.8       44.8
Foreign currency translation adjustment 7.3     7.3  
Stock-based compensation expense, net 5.5   5.5    
Settlement of stock-based awards (in shares)   0.3      
Settlement of stock-based awards 0.0        
Ending balance (in shares) at May. 03, 2025   447.3      
Ending balance at May. 03, 2025 $ 4,987.4 $ 0.2 5,110.6 (86.7) (36.7)
Beginning balance (in shares) at Feb. 01, 2025 447.0 447.0      
Beginning balance at Feb. 01, 2025 $ 4,929.8 $ 0.2 5,105.1 (94.0) (81.5)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 290.5        
Foreign currency translation adjustment 21.9        
Warrant distribution $ 173.9        
Ending balance (in shares) at Nov. 01, 2025 447.9 447.9      
Ending balance at Nov. 01, 2025 $ 5,303.0 $ 0.2 5,297.5 (72.0) 77.3
Beginning balance (in shares) at May. 03, 2025   447.3      
Beginning balance at May. 03, 2025 4,987.4 $ 0.2 5,110.6 (86.7) (36.7)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 168.6       168.6
Foreign currency translation adjustment 14.1     14.1  
Stock-based compensation expense, net 6.3   6.3    
Settlement of stock-based awards (in shares)   0.3      
Settlement of stock-based awards 0.0        
Ending balance (in shares) at Aug. 02, 2025   447.6      
Ending balance at Aug. 02, 2025 5,176.4 $ 0.2 5,116.9 (72.6) 131.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 77.1       77.1
Foreign currency translation adjustment 0.5     0.5  
Stock-based compensation expense, net 7.7   7.7    
Unrealized gain on Marketable Securities and gain on available-for-sale securities 0.1     0.1  
Settlement of stock-based awards 0.0        
Warrant distribution $ 41.2   172.9   (131.7)
Ending balance (in shares) at Nov. 01, 2025 447.9 447.9      
Ending balance at Nov. 01, 2025 $ 5,303.0 $ 0.2 $ 5,297.5 $ (72.0) $ 77.3